Bora Pharmaceuticals Co., LTD. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
August 14, 2023 at 12:15 pm IST
Share
Bora Pharmaceuticals Co., LTD. reported earnings results for the second quarter and six months ended June 30, 2023. For the second quarter, the company reported sales was TWD 3,138.57 million compared to TWD 1,354.64 million a year ago. Net income was TWD 692.03 million compared to TWD 239.99 million a year ago. Basic earnings per share from continuing operations was TWD 6.8904 compared to TWD 2.4636 a year ago. Diluted earnings per share from continuing operations was TWD 6.7826 compared to TWD 2.4559 a year ago.
For the six months, sales was TWD 7,919.1 million compared to TWD 2,471.89 million a year ago. Net income was TWD 1,731.37 million compared to TWD 419.17 million a year ago. Basic earnings per share from continuing operations was TWD 17.3531 compared to TWD 4.2882 a year ago. Diluted earnings per share from continuing operations was TWD 16.922 compared to TWD 4.2882 a year ago.
Bora Pharmaceuticals Co Ltd is a Taiwan-based company principally engaged in the agency and sales of western medicines, as well as the research, development, manufacture and sales of new drugs and health products. The Company's main products are categorized into prescription drugs and health care products, including central nervous drugs, cardiovascular drugs, antibiotics, antiviral agents, ophthalmic drugs, gastrointestinal drugs, foam ingots and health care products. In addition, the Company has biopharmaceutical technologies related to the development of cell lines for the production of protein drugs, the development and analysis of upstream and downstream processes, as well as the establishment of quality control and testing specifications and the creation of cell banks.
BORA PHARMACEUTICALS CO., LTD. 
